Table 3 CD-associated characteristics of the 20 patients
From: The pathological and outcome characteristics of renal lesions in Crohn’s disease
Clinical characteristic | Data |
|---|---|
Montreal classification — no. (%) | |
Age at CD diagnosis (A) | |
A1 (Not more than 16 years) | 1 (5%) |
A2 (More than17 years but no more than 40 years) | 15 (75%) |
A3 (More than 40 years) | 4 (20%) |
Location (L) | |
L1 (Ileal) | 1 (5%) |
L2 (Colonic) | 0 (0%) |
L3 (Ileocolonic) | 19 (95%) |
L4 (Upper gastrointestinal) | 11 (55%) |
Behavior (B) | |
B1 (Non-stricturing and non-penetrating) | 12 (60%) |
B2 (Stricturing) | 0 (0%) |
B3 (Penetrating) | 8 (40%) |
P (Perianal disease) | 14 (70%) |
Age at CD diagnosis — yr | 28.70±11.63 |
Duration of CDa — mth | 84.00±77.81 |
CDAIb | 244.05±130.76 |
Active CDc — no. (%) | 13 (65%) |
Erythrocyte sedimentation rate — mm per hr | 46.70±39.59 |
C-reactive protein — mg per L | 18.85±24.41 |
CD-related gastrointestinal surgery — no. (%) | 7 (35%) |
CD treatment — no. (%) | |
5-aminosalicylic acid | 1 (5%) |
Glucocorticoids | 2 (10%) |
Biological agents | 9 (45%) |
Immunosuppressive agents | 15 (75%) |
Antibioticsd | 0 (0%) |
Enteral nutrition | 4 (20%) |